| NCT Number | NCT05496556 |
| Lead Sponsor | Centre Georges Francois Leclerc |
| Conditions | Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French Recommendations |
| Enrollment | 190 participants |
| Start Date | 2023-11-01 |
| Primary Completion | 2026-10-01 (estimated) |
| Study Completion | 2026-10-01 (estimated) |
| Updated on ClinicalTrials.gov | 2025-12-01 |